King Names COO Markison Acting CEO; President Macione Steps Down
King Pharmaceuticals Chief Operating Officer Brian Markison has been named acting president and CEO
You may also be interested in...
Mylan's proposed acquisition of King is a big move by the generic company to carve out a leading position in the branded antihypertensive market
King Pharmaceuticals is working with wholesalers to implement an inventory reduction program to help stabilize Altace stocking levels, CFO Jim Lattanzi said during a Feb. 19 conference call
King Pharmaceuticals is raising its estimated Medicaid rebate underpayments by $18.9 mil. to $65.4 mil. following the completion of an internal audit, CFO Jim Lattanzi said during a Feb. 19 conference call